Amarex logo

Wound care dressing set - Wound Healing Clinical Trials | Amarex

Wound Healing

Numerous wound care products are available on the market, from OTC to prescription. Most of these are topical products approved as medical devices. Clinical development aims at ensuring timely wound healing and effective infection control, with some products being updated and improved upon, and others being altogether new technologies. Challenges to wound healing trials include heterogeneity of the patient population, variations in standard wound care procedures, and poorly defined wound assessment and quantifications measures.

Our team has a broad array of wound healing clinical trial experience and expertise. We have worked on everything from dressings and debridement, to infection potentiation products, to implantable devices. We have a track history of successful wound care R&D, including three product approvals and several rescue trials.

Our Experience:

  • 20+ years of clinical product development
  • 15+ years working on wound healing products
  • 85+ wound healing clinical projects
  • Product types: Drugs (NCEs, botanicals, biologics, cell therapies and gene therapies), devices and diagnostics
  • Clinical trials: 56+ (Phase I-IV), 1,250+ sites, 12,250+ patients
  • Proof of concept through FDA marketing approval
  • Regulatory services: Multiple OCP, IND, NDA, BLA, 510(k), IDE, PMA and ANDA application submissions
  • Full-scope and targeted-scope projects
  • Several rescues of wound healing trials
  • One 510(k) and two PMA wound healing market approvals

Therapeutic Indications:

  • Burn wounds
  • Chronic wounds
  • Diabetic foot ulcer (DFU)
  • Hypertropic scars
  • Internal tissue damage repair
  • Laceration wounds
  • Pressure ulcers (PUs)
  • Skin graft wounds (split-skin)
  • Surgical wounds
  • Tissue regeneration
  • Venous leg ulcer (VLU)
  • Wound debridement
  • Wound infection

Product Types:

  • Antibiotic, anti-infective and antimicrobial
  • Combination biologics
  • Cultured skin substitute
  • Enzyme alginogel
  • Membranes (bilayer and cellular)
  • Micro gel (PEGylated fibrinogen)
  • Nitric oxide
  • Orthobiologics
  • Oxygen therapy
  • Peptides
  • Purified hemoglobin
  • SEM scanner
  • siRNA
  • Suture with stem cells
  • Synthetic DNA oligonucleotide
  • Synthetic extracellular matrix
  • Topical adhesive
  • Topical cream
  • Umbilical cord blood (UCB) derived therapy
  • Businesspeople in Amarex corporate building - Resources | Amarex

    Resources

    Find up-to-date resources from our scientists, researchers and lead team members.
  • Amarex CEO Kazem Kazempour with staff - Leadership | Amarex

    Leadership

    Meet our leadership team and learn more about their expertise and commitment to advancing clinical product development.

Contact Us

Book a meeting or send us a message to talk to one of our experts.